Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

AcryMed

AcryMed?uq=w9if130k
1993 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
$26.7M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of a proprietary wound care technologies. The company has focused their efforts on identifying solutions to enhance the efficacy of medical products and improve patient care.

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 9560 South West Nimbus Avenue
  • Beaverton, OR 97008
  • United States

+1 (503) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AcryMed’s full profile, request a free trial.

AcryMed Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 15-Feb-2008 $26.7M 00.00 000.00 Completed Generating Revenue
2. Early Stage VC 01-Jan-1996 00.00 00.00 Completed Startup
1. Early Stage VC 01-Jan-1995 $900K $900K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

AcryMed Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Fluke Venture Partners Venture Capital Minority 000 0000 000000 0
Pacific Northwest Partners Corporation Minority 000 0000 000000 0

AcryMed Executive Team (1)

Name Title Board
Seat
Contact
Info
Dan Pike Ph.D General Manager & Business Development Leader